Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders

NeuroMolecular Medicine

Volumn 3, Issue 2, 2003, Pages 65-94

  Mattson, Mark P ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Calcium; Glutamate; Huntington's disease; Mitochondria; Neurotrophic factor; Oxidative stress; Parkinson's disease; Stroke

Indexed keywords

3 AMINOBENZAMIDE; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCINEURIN INHIBITOR; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CASPASE INHIBITOR; CYCLOSPORIN A; CYTOCHALASIN D; DANTROLENE; DIAZEPAM; DIAZOXIDE; DIZOCILPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUTAMATE RECEPTOR ANTAGONIST; KYNURENIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; PACLITAXEL; PHENOBARBITAL; PROTEINASE INHIBITOR; TACROLIMUS; THIOCTIC ACID; TOCOPHEROL; UNINDEXED DRUG; URIC ACID DERIVATIVE; GLUTAMATE RECEPTOR; NEUROTOXIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN INJURY; CELL NUCLEUS; CELL ORGANELLE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DENDRITE; DRUG TARGETING; ENDOPLASMIC RETICULUM; EPILEPSY; GLIA CELL; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL MEMBRANE; NERVE CELL; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONCENTRATION; PARKINSON DISEASE; PARTHENOGENESIS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STRESS; STROKE; ANIMAL; CELL DEATH; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL DEATH; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 0043180531     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:3:2:65     Document Type: Review

References (282)

1. Agrawal S. K. and Fehlings M. G. (1997) Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J. Neurosci. 17, 1055-1063.
2. Aizenman E., Hartnett K. A., and Reynolds I. J. (1990) Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 5, 841-846.
3. Akins P. T. and Atkinson R. P. (2002) Glutamate AMPA receptor antagonist treatment for ischaemic stroke. Curr. Med. Res. Opin. 18, S9-13.
4. Albensi B. C., Sullivan P. G., Thompson M. B., Scheff S. W., and Mattson M. P. (2000) Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity. Exp. Neurol. 162, 385-389.
5. Allen J. W., Ivanova S. A., Fan L., Espey M. G., Basile A. S., and Faden A. I. (2000) Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J. Pharmacol. Exp. Ther. 290, 112-120.
6. Allsopp T. E., Kiseley S., Wyatt S., and Davies A. M. (1995) Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur. J. Neurosci. 7, 1266-1272.
7. Andreassen O. A., Dedeoglu A., Ferrante R. J., et al. (2001a) Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol. Dis. 8, 479-491.
8. Andreassen O. A., Dedeoglu A., Friedlich A., Ferrante K. L., Hughes D., Szabo C., and Beal M. F. (2001b) Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp. Neurol. 168, 419-424.
9. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., and Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
10. Ankarcrona M. (1998) Glutamate induced cell death: apoptosis or necrosis? Prog. Brain Res. 116, 265-272.
11. Armijo J. A., Valdizan E. M., De Las Cuevas I., and Cuadrado A. (2002) Advances in the physiopathology of epileptogenesis: molecular aspects. Rev. Neurol. 34, 409-429.
12. Azbill R. D., Mu X., Bruce-Keller A. J., Mattson M. P., and Springer J. E. (1997) Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765, 283-290.
13. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92, 9328-9332.
14. Barger S. W. and Mattson M. P. (1996) Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Mol. Brain Res. 40, 116-126.
15. Beal M. F., Matthews R. T., Tieleman A., and Shults C. W. (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 783, 109-114.
16. Ben-Ari Y. and Cossart R. (2000) Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23, 580-587.
17. Berg M., Bruhn T., Frandsen A., Schousboe A., and Diemer N. H. (1995) Kainic acid-induced seizures and brain damage in the rat: role of calcium homeostasis. J. Neurosci. Res. 40, 641-646.
18. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
19. Bezzi P., Domercq M., Vesce S., and Volterra A. (2001) Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog. Brain Res. 132, 255-265.
20. Bi X., Chang V., Siman R., Tocco G., and Baudry M. (1996) Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain. Brain Res. 726, 98-108.
21. 2+ homeostasis and cell death. J. Neurochem. 70, 958-970.
22. Borlongan C. V. and Sanberg P. R. (2002) Neural transplantation for treatment of Parkinson's disease. Drug Discov. Today 7, 674-682.
23. Bough K. J., Gudi K., Han F. T., Rathod A. H., and Eagles D. A. (2002) An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res. 50, 313-325.
24. Boxer P. A., Cordon J. J., Mann M. E., Rodolosi L. C., Vartanian M. G., Rock D. M., Taylor C. P., and Marcoux F. W. (1990) Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21, III47-51.
25. Brandt J., Bylsma F. W., Gross R., Stine O. C., Ranen N., and Ross C. A. (1996) Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46, 527-531.
26. Bredt D. S. and Snyder S. H. (1992) Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
27. Brewer G. J. and Wallimann T. W. (2000) Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74, 1968-1978.
28. 2+ homeostasis in hippocampal neurons. J. Neurochem. 68, 95-105.
29. Brouillet E., Conde E, Beal M. E, and Hantraye P. (1999) Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59, 427-468.
30. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., and Mattson M. P. (1996) Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors. Nature Medicine 2, 788-794.
31. Bruce-Keller A. J., Begley J. G., Fu W., Butterfield D. A., Bredesen D. E., Hutchins J. B., Hensley K., and Mattson M. P. (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J. Neurochem. 70, 31-39.
32. Bruce-Keller A. J., Umberger G., McFall R., and Mattson M. P. (1999) Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45, 8-15.
33. Brustovetsky N., Brustovetsky T., and Dubinsky J. M. (2001) On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76, 425-434.
34. Bullock M. R., Merchant R. E., Carmack C. A., Doppenberg E., Shah A. K., Wilner K. D., Ko G., and Williams S. A. (1999) An open-label study of CP-101, 606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. Ann. NY Acad. Sci. 890, 51-58.
35. Burns M. and Duff K. (2002) Cholesterol in Alzheimer's disease and tauopathy. Ann. NY Acad. Sci. 977, 367-375.
36. Caba E., Brown Q. B., Kawasaki B., and Bahr B. A. (2002) Peptidyl alpha-keto amide inhibitor of calpain blocks excitotoxic damage without affecting signal transduction events. J. Neurosci. Res. 67, 787-794.
37. Cendes F., Andermann F., Carpenter S., Zatorre R. J., and Cashman N. R. (1995) Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans. Ann. Neurol. 37, 123-126.
38. Chan P. H., Chu L., Chen S. E, Carlson E. J., and Epstein C. J. (1990) Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. Stroke 21, III80-III82.
39. Chan S. L., Griffin W. S. T., and Mattson M. P. (1999) Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and in Alzheimer's disease. J. Neurosci. Res. 57, 315-323.
40. Chen R. W. and Chuang D. M. (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J. Biol. Chem. 274, 6039-6042.
41. Chen Q. S., Wei W. Z., Shimahara T., and Xie C. W. (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77, 354-371.
42. Cheng B. and Mattson M. P. (1991) NGF and bFGF protect rat and human central neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
43. Cheng B. and Mattson M. P. (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12, 1558-1566.
44. Cheng B. and Mattson M. P. (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640, 56-67.
45. Cheng B., Goodman Y., Begley J. G., and Mattson M. P. (1994a) Neurotrophin 4/5 protects hippocampal and cortical neurons against energy deprivation- and excitatory amino acid-induced injury. Brain Res. 650, 331-335.
46. Cheng B., Christakos S., and Mattson M. P. (1994b) Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
47. Cheng B. and Mattson M. P. (1995) PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J. Neurosci. 15, 7095-7104.
48. 2+ responses to AMPA and NMDAin hippocampal neurons. J. Neurochem. 65, 2525-2536.
49. Cluskey S. and Ramsden D. B. (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 54, 386-392.
50. Collins R. C., Dobkin B. H., and Choi D. W. (1989) Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann. Intern. Med. 110, 992-1000.
51. Conover J. C. and Yancopoulos G. D. (1997) Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev. Neurosci. 8, 13-27.
52. Cox P. A. and Sacks O. W. (2002) Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 58, 956-959.
53. Culcasi M., Lafon-Cazal M., Pietri S., and Bockaert J. (1994) Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J. Biol. Chem. 269, 12,589-12,593.
54. Culmsee C., Zhu X., Yu Q. S., Chan S. L., Camandola S., Guo Z., Greig N. H., and Mattson M. P. (2001) A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77, 220-228.
55. Cutler R. G., Pedersen W. A., Camandola S., Rothstein J. D., and Mattson M. P. (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in ALS. Ann. Neurol. 52, 448-457.
56. Dargusch R., Piasecki D., Tan S., Liu Y., and Schubert D. (2001) The role of Bax in glutamate-induced nerve cell death. J. Neurochem. 76, 295-301.
57. David J. C., Yamada K. A., Bagwe M. R., and Goldberg M. P. (1996) AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. J. Neurosci. 16, 200-209.
58. Davis S. M., Lees K. R., Albers G. W., Diener H. C., Markabi S., Karlsson G., and Norris J. (2000) Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31, 347-354.
59. Dawson V. L., Kizushi V. M., Huang P. L., Snyder S. H., and Dawson T. M. (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479-2487.
60. Dawson V. L. and Dawson T. M. (1998) Nitric oxide in neurodegeneration. Prog. Brain Res. 118, 215-229.
61. Dawson T. M. and Dawson V. L. (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J. Clin. Invest. 111, 145-151.
62. Decker P. and Muller S. (2002) Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr. Pharm. Biotechnol. 3, 275-283.
63. Didier M., Bursztajn S., Adamec E., Passani L., Nixon R. A., Coyle J. T., Wei J. Y., and Berman S. A. (1996) DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 16, 2238-2250.
64. Dirnagl U., Iadecola C., and Moskowitz M. A. (1999) Pathobiology of ischemic stroke: an integrated review. Trends Neurosci. 22, 391-397.
65. Dixon C. E., Flinn P., Bao J., Venya R., and Hayes R. L. (1997) Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp. Neurol. 146, 479-490.
66. Doble A. (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81, 163-221.
67. Drachman D. B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J. D. (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52, 771-778.
68. Du Y. and Dreyfus C. F. (2002) Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 68, 647-654.
69. Du Y., Bales K. R., Dodel R. C., Hamilton-Byrd E., Horn J. W., Czilli D. L., Simmons L. K., Ni B., and Paul S. M. (1997) Activation of a caspase 3-related cysteine protease is required for glutamate mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA 94, 11,657-11,662.
70. Duan W. and Mattson M. P. (1999) Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195-206.
71. Duan W., Rangnekar V. M., and Mattson M. P. (1999) Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72, 2312-2322.
72. Duan W., Guo Z., and Mattson M. P. (2001) Brain-derived neurotrophic factor mediates an excito-protective effect of dietary restriction in mice. J. Neurochem. 76, 619-626.
73. Duan W., Zhu X., Ladenheim B., Yu Q. S., Guo Z., Oyler J., Cutler R. G., Cadet J. L., Greig N. H., and Mattson M. P. (2002a) p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann. Neurol. 52, 597-606.
74. Duan W., Ladenheim B., Cutler R. G., Kruman I. I., Cadet J. L., and Mattson M. P. (2002b) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem. 80, 101-110.
75. Duan W., Guo Z., Jiang H., Ware M., Li X. J., and Mattson M. P. (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression and increases survival in Huntingtin mutant mice. Proc. Natl. Acad. Sci. USA 100, 2911-2916.
76. Duchen M. R. (2000) Mitochondria and calcium: from cell signalling to cell death. J. Physiol. 529, 57-68.
77. Dugan L. L., Sensi S. L., Canzoniero L. M., Handran S. D., Rothman S. M., Goldberg M. P., and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exsposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
78. Eldadah B. A. and Faden A. I. (2000) Caspase pathways, neuronal apoptosis, and CNS injury. J. Neurotrauma. 17, 811-829.
79. Elliott E., Mattson M. P., Vanderklish P., Lynch G., Chang I., and Sapolsky R. M. (1993) Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61, 57-67.
80. Endres M., Wang Z. Q., Namura S., Waeber C., and Moskowitz M. A. (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 17, 1143-1151.
81. Endres M., Fink K., Zhu J., Stagliano N. E., Bondada V., Geddes J. W., Azuma T., Mattson M. P., Kwiatkowski D. J., and Moskowitz M. A. (1999) Neuroprotective effects of gelsolin and cytochalasin D during murine stroke. J. Clin. Invest 103, 347-354.
82. Espey M. G., Chernyshev O. N., Reinhard J. F. Jr., Namboodiri M. A., and Colton C. A. (1997) Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport. 8, 431-434.
83. Feger J., Pessigliore M., Francois C., Tremblay L., and Hirsch E. (2002) Experimental models of Parkinson's disease. Ann. Pharm. Fr. 60, 3-21.
84. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H., and Beal M. F. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074.
85. Ferrante R. J., Andreassen O. A., Dedeoglu A., Ferrante K. L., Jenkins B. G., Hersch S. M., and Beal M. F. (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci. 22, 1592-1599.
86. Frandsen A. and Schousboe A. (1991) Dantrolene prevents glutamate cytotoxicity and calcium release from intracelluar stores in cultured cerebral cortical neurons. J. Neurochem. 56, 1075-1078.
87. Fuller T. A. and Olney J. W. (1981) Only certain anti-convulsants protect against kainate neurotoxicity. Neurobehav. Toxicol. Teratol. 3, 355-361.
88. 2+]i and protects hippocampal neurons against excitotoxicity. Brain Res. 689, 141-146.
89. 2+]i. Exp. Neurol. 133, 153-163.
90. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379, 74-78.
91. Furukawa K., Fu W., Li Y., Witke W., Kwiatkowski D. J., and Mattson M. P. (1997) The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178-8186.
92. Furukawa K. and Mattson M. P. (1998) The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA and AMPA/kainate-induced currents in response to TNFα in hippocampal neurons. J. Neurochem. 70, 1876-1886.
93. Furukawa K., De Souza I., and Scheuenberg G. (2002) Tau mutations in FTDP-17 potentiate calcium release from intracellular stores and activate apoptotic pathways. Neurobiol. Aging 23, S132
94. Gabriel C., Ali C., Lesne S., et al. (2003) Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J. 17, 277-279.
95. Gallo V. and Russell J. T. (1995) Excitatory amino acid receptors in glia: different subtypes for distinct functions? J. Neurosci. Res. 42, 1-8.
96. Gariballa S. E. (2000) Nutritional factors in stroke. Br. J. Nutr. 84, 5-17.
97. Gary D. S., Bruce-Keller A. J., Kindy M. S., and Mattson M. P. (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18, 1283-1287.
98. Gary D. S. and Mattson M. P. (2001) Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J. Neurochem. 76, 1485-1496.
99. Gary D. S., Milhavet O., Camandola S., and Mattson M. P. (2003) Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84, 878-890.
100. Gaviria M., Privat A., d'Arbigny P., Kamenka J., Haton H., and Ohanna F. (2000) Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res. 874, 200-209.
101. Gilman C. P. and Mattson M. P. (2002) Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromolecular Med. 2, 197-214.
102. Giusti P., Lipartiti M., Franceschini D., Schiavo N., Floreani M., and Manev H. (1996) Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10, 891-896.
103. Glazner G. W. and Mattson M. P. (1999) Differential effects of BDNF, ADNF-9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp. Neurol. 161, 442-452.
104. Glazner G. W., Chan S. L., Lu C., and Mattson M. P. (2000) Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641-3649.
105. Goodman Y. and Mattson M. P. (1994) Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
106. Goodman Y., Steiner M. R., Steiner S. M., and Mattson M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171-176.
107. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res. 706, 328-332.
108. Goodman Y., Bruce A. J., Cheng B., and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
109. Gorgias N., Maidatsi P., Tsolaki M., Alvanou A., Kiriazis G., Kaidoglou K., and Giala M. (1996) Hypoxic pretreatment protects against neuronal damage of the rat hippocampus induced by severe hypoxia. Brain Res. 714, 215-225.
110. Grondin R., Zhang Z., Yi A., Cass W. A., Maswood N., Andersen A. H., Elsberry D. D., Klein M. C., Gerhardt G. A., and Gash D. M. (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain. 125, 2191-2201.
111. Gunasekar P. G., Kanthasamy A. G., Borowitz J. L., and Isom G. E. (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J. Neurochem. 65, 2016-2021.
112. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N., Martin G. M., and Mattson M. P. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport. 8, 379-383.
113. Guo Q., Sopher B. L., Furukawa K., Pham D. G., Robinson N., Martin G. M., and Mattson M. P. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
114. Guo Q., Fu W., Xie J., Luo H., Sells S. F., Geddes J. W., Bondada V., Rangnekar V., and Mattson M. P. (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nature Med. 4, 957-962.
115. Guo Q., Sebastian L., Sopher B. L., Miller M. W., Glazner G. W., Ware C. B., Martin G. M., and Mattson M. P. (1999) Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a presenilin-1 mutation. Proc. Natl. Acad. Sci. USA 96, 4125-4130.
116. Guo Q., Fu W., Sopher B. L., Miller M. W., Ware C. B., Martin G. M., and Mattson M. P. (1999a) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med. 5, 101-107.
117. Guo Q., Sebastian L., Sopher B. L., Miller M. W., Glazner G. W., Ware C. V., Martin G. M., and Mattson M. P. (1999b) Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc. Natl. Acad. Sci. USA 96, 4125-4130.
118. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., and Hall E. D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
119. Guttmann R. P., Sokol S., Baker D. L., Simpkins K. L., Dong Y., and Lynch D. R. (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J. Pharmacol. Exp. Ther. 302, 1023-1030.
120. Hadley M. N., Zabramski J. M., Spetzler R. F., Rigamonti D., Fifield M. S., and Johnson P. C. (1989) The efficacy of intravenous nimodipine in the treatment of focal cerebral ischemia in a primate model. Neurosurgery 25, 63-70.
121. Hall E. D. (1993) The role of oxygen radicals in traumatic injury: clinical implications. J. Emerg. Med. 11, S31-36.
122. Hara H., Nagasawa H., and Kogure K. (1990) Nimodipine prevents postischemic brain damage in the early phase of focal cerebral ischemia. Stroke 21, IV102-104.
123. Hara H., Kato H., and Kogure K. (1990) Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res. 510, 335-338.
124. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
125. Haydon P. G. (2001) GLIA: listening and talking to the synapse. Nat. Rev. Neurosci. 2, 185-193.
126. Hayes R. L., Jenkins L. W., and Lyeth B. G. (1992) Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma 9, S173-S187.
127. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., and Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
128. Hurlbert M. S., Zhou W., Wasmeier C., Kaddis F. G., Hutton J. C., and Freed C. R. (1999) Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48, 649-651.
129. Iadecola C., Zhang E, Casey R., Nagayama M., and Ross M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164.
130. Ikonomidou C. and Turski L. (1996) Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab. Brain Dis. 11, 125-141.
131. Kakarieka A., Schakel E. H., and Fritze J. (1994) Clinical experiences with nimodipine in cerebral ischemia. J. Neural. Transm. Suppl. 43, 13-21.
132. Kamii H., Mikawa S., Murakami K., Kinouchi H., Yoshimoto T., Reola L., Carlson E., Epstein C. J., and Chan P. H. (1996) Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16, 1153-1157.
133. Kawasaki-Yatsugi S., Shimizu-Sasamata M., Yatsugi S., and Yamaguchi T. (1998) Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats. J. Pharm. Pharmacol. 50, 891-898.
134. Keller J. N., Mark R. J., Bruce A. J., Blanc E. M., Rothstein J. D., Uchida K., and Mattson M. P. (1997a) 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685-696.
135. +-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50, 522-530.
136. Keller J. N., Kindy M. S., Holtsberg F. W., et al. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687-697.
137. Kelsey J. E., Sanderson K. L., and Frye C. A. (2000) Perforant path stimulation in rats produces seizures, loss of hippocampal neurons, and a deficit in spatial mapping which are reduced by prior MK-801. Behav. Brain Res. 107, 59-69.
138. Khodorov B., Pinelis V., Vergun O., Storozhevykh T., and Vinskaya N. (1996) Mitochondrial deenergization underlies neuronal calcium overload following a prolonged glutamate challenge. FEBS Lett. 397, 230-234.
139. Kilpatrick G. J. and Tilbrook O. S. (2002) Memantine. Merz. Curr. Opin. Investig. Drugs 3, 798-806.
140. Kim B. T., Rao V. L., Sailor K. A., Bowen K. K., and Dempsey R. J. (2001) Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats. J. Neurosurg. 95, 674-679.
141. Koketsu N., Berlove D. J., Moskowitz M. A., Kowall N. W., Caday C. G., and Finklestein S. P. (1994) Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35, 451-457.
142. Kondratyev A. and Gale K. (2000) Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Mol. Brain Res. 75, 216-224.
143. Kroemer G., Zamzami N., and Susin S. A. (1997) Mitochondrial control of apoptosis. Immunol. Today 18, 44-51.
144. Kruman I., Bruce-Keller A. J., Bredesen D. E., Waeg G., and Mattson M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5089-5100.
145. Kruman I. I., Pedersen W. A., Springer J. E., and Mattson M. P. (1999) ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160, 28-39.
146. Kruman I. I., Culmsee C., Chan S. L., Kruman Y., Guo Z., Penix L., and Mattson M. P. (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926.
147. Kruman I. I., Kumaravel T. S., Lohani A., Pedersen W. A., Cutler R. G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M. P. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762.
148. Kullmann D. M., Asztely F., and Walker M. C. (2000) The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy. Cell Mol. Life Sci. 57, 1551-1561.
149. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
150. Le W. D., Colom L. V., Xie W. J., Smith R. G., Alexianu M., and Appel S. H. (1995) Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res. 686, 49-60.
151. Lee J., Duan W., and Mattson M. P. (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82, 1367-1375.
152. Lees K. R., Asplund K., Carolei A., Davis S. M., Diener H. C., Kaste M., Orgogozo J. M., and Whitehead J. (2000) Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet 355, 1949-1954.
153. Legos J. J., Tuma R. F., and Barone F. C. (2002) Pharmacological interventions for stroke: failures and future. Expert Opin. Investig. Drugs. 11, 603-614.
154. Leist M., Volbracht C., Kuhnle S., Fava E., Ferrando-May E., and Nicotera P. (1997) Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3, 750-764.
155. Lewen A., Matz P., and Chan P. H. (2000) Free radical pathways in CNS injury. J. Neurotrauma. 17, 871-890.
156. Linnik M. D., Zobrist R. H., and Hatfield M. D. (1993) Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008.
157. 2+ channels in sympathetic neurons. Neuron 1, 355-365.
158. Lipsky R. H., Xu K., Zhu D., Kelly C., Terhakopian A., Novelli A., and Marini A. M. (2001) Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J. Neurochem. 78, 254-264.
159. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S. V., Sucher N. J., Loscaizo J., Singel D. J., and Stamler J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
160. Liu W., Liu R., Chun J. T., Bi R., Hoe W., Schreiber S. S., and Baudry M. (2001) Kainate excitotoxicity in organotypic hippocampal slice cultures: evidence for multiple apoptotic pathways. Brain Res. 916, 239-248.
161. Liu B., Gao H. M., Wang J. Y., Jeohn G. H., Cooper C. L., and Hong J. S. (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci. 962, 318-331.
162. Liu D., Lu C., Wan R., Auyeung W. W., and Mattson M. P. (2002) Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 22, 431-443.
163. Liu D., Slevin J. R., Chan S. L., and Mattson M. P. (2003) Inhibition of mitochondrial potassium channels reduces focal ischemic brain damage and suppresses oxyradical production and apoptotic cascades. J. Neurochem. (In press).
164. Lockwood A. H. (2000) Pesticides and parkinsonism: is there an etiological link? Curr. Opin. Neurol. 13, 687-690.
165. Loetscher H., Niederhauser O., Kemp J., and Gill R. (2001) Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? Drug Discov. Today. 6, 671-680.
166. Lowenstein D. H., Chan P. H., and Miles M. F. (1991) The stress protein response in neurons: characterization and evidence for a protective role in excitotoxicity. Neuron 7, 1053-1060.
167. Lu C. B., Fu W., and Mattson M. P. (2001) Caspase-mediated suppression of glutamate (AMPA) receptor channel activity in hippocampal neurons in response to DNA damage promotes apoptosis and prevents necrosis: implications for neurological side effects of cancer therapy and neurodegenerative disorders. Neurobol. Dis. 8, 194-206.
168. 2+ channels in neurons by increasing protein tyrosine phosphorylation. J. Biol. Chem. 277, 24,368-24,375.
169. Lu C., Fu W., and Mattson M. P. (2002) Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. NeuroMolecular Med. 1, 69-79.
170. Ludolph A. C., Meyer T., and Riepe M. W. (2000) The role of excitotoxicity in ALS - what is the evidence? J. Neurol. 247, 17-116.
171. Luchsinger J. A., Tang M. X., Shea S., and Mayeux R. (2002) Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59, 1258-1263.
172. Manabe Y., Nagano I., Gazi M. S., Murakami T., Shiote M., Shoji M., Kitagawa H., Setoguchi Y., and Abe K. (2002) Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Apoptosis 7, 329-334.
173. Marini A. M. and Paul S. M. (1992) N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc. Natl. Acad. Sci. USA 89, 6555-6559.
174. Marini A. M., Rabin S. J., Lipsky R. H., and Mocchetti I. (1998) Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J. Biol. Chem. 273, 29,394-29,399.
175. Marion D. W. (1998) Head and spinal cord injury. Neurol. Clin. 16, 485-502.
176. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
177. Mark R. J., Ashford J. W., Goodman Y., and Mattson M. P. (1995b) Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging 16, 187-198.
178. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997a) A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
179. Mark R. J., Pang Z., Geddes J. W., Uchida K., and Mattson M. P. (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
180. Martinou J. C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., and Pietra C. (1994) Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017-1030.
181. Matthews R. T., Ferrante R. J., Klivenyi P., Yang L., Klein A. M., Mueller G., Kaddurah-Daouk R., and Beal M. F. (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp. Neurol. 157, 142-149.
182. Mattson M. P., Dou P., and Kater S. B. (1988) Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8, 2087-2100.
183. Mattson M. P. and Kater S. B. (1989) Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture. Brain Res. 478, 337-348.
184. Mattson M. P., Murrain M., Guthrie P. B., and Kater S. B. (1989) Fibroblast growth factor and glutamate: Opposing actions in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728-3740.
185. 2+ extrusion in protection against neuronal excitotoxicity. FASEB J. 3, 2519-2526.
186. Mattson M. P. and Rychlik B. (1990) Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J. Dev. Neurosci. 8, 399-415.
187. Mattson M. P., Rychlik B., Chu C., and Christakos S. (1991) Evidence for calcium-reducing and excitoprotective roles for the calcium binding protein (calbindin-D28k) in cultured hippocampal neurons. Neuron 6, 41-51.
188. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
189. Mattson M. P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10, 243-254.
190. Mattson M. P., Zhang Y., and Bose S. (1993) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121, 1-13.
191. Mattson M. P., Kumar K., Cheng B., Wang H., and Michaelis E. K. (1993) Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J. Neurosci. 13, 4575-4588.
192. Mattson M. P. and Scheff S. W. (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma 11, 3-33.
193. 2+]i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
194. Mattson M. P. (1997) Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21, 193-206.
195. Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
196. Mattson M. P. (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21, 53-57.
197. Mattson M. P., Keller J. N., and Begley J. G. (1998) Evidence for synaptic apoptosis. Exp. Neurol. 153, 35-48.
198. Mattson M. P., Zhu H., Yu J., and Kindy M. S. (2000) Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20, 1358-1364.
199. Mattson M. P. and Camandola S. (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254.
200. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A., and Sanchez-Gomez M. V. (2001). The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24, 224-230.
201. McAdoo D. J., Xu G. Y., Robak G., and Hughes M. G. (1999) Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp. Neurol. 159, 538-544.
202. McDonald J. W., Althomsons S. P., Hyrc K. L., Choi D. W., and Goldberg M. P. (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/ kainate receptor-mediated excitotoxicity. Nat. Med. 4, 291-297.
203. McNaught K. S. and Jenner P. (2000) Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. Biochem. Pharmacol. 60, 979-988.
204. Meldrum B. S., Akbar M. T., and Chapman A. G. (1999) Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res. 36, 189-204.
205. Menalled L. B. and Chesselet M. F. (2002) Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23, 32-39.
206. Michaelis E. K. (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54, 369-415.
207. Milatovic D., Gupta R. C., and Dettbarn W. D. (2002) Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res. 957, 330-337.
208. Mills C. D., Johnson K. M., and Hulsebosch C. E. (2002) Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain. J. Neurotrauma. 19, 23-42.
209. Miranda A. F., Boegman R. J., Beninger R. J., and Jhamandas K. (1997) Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience 78, 967-975.
210. Mizota A., Sato E., Taniai M., Adachi-Usami E., and Nishikawa M. (2001) Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest. Ophthalmol. Vis. Sci. 42, 216-221.
211. Moriwaki A., Lu Y. F., Tomizawa K., and Matsui H. (1998) An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. Neuroscience 86, 855-865.
212. Mossakowski M. J. and Gadamski R. (1990) Nimodipine prevents delayed neuronal death of sector CA1 pyramidal cells in short-term forebrain ischemia in mongolian gerbils. Stroke 21, IV120-122.
213. Muller U. and Krieglstein J. (1995) Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J. Cereb. Blood Flow Metab. 5, 624-630.
214. Nag D., Garg R. K., and Varma M. (1998) A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke. Indian. J. Physiol. Pharmacol. 42, 555-558.
215. Nagano S., Ogawa Y., Yanagihara T., and Sakoda S. (1999) Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci. Lett. 265, 159-162.
216. Nellgard B. and Wieloch T. (1992) Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp. Brain Res. 92, 259-266.
217. Nicholls D. G., Budd S. L., Ward M. W., and Castilho R. F. (1999) Excitotoxicity and mitochondria. Biochem. Soc. Symp. 66, 55-67.
218. Novelli A., Reilly J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
219. Nozaki K., Finklestein S. P., and Beal M. F. (1993) Basic fibroblast growth factor protects against hypoxiaischemia and NMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Metab. 13, 221-228.
220. Nuglisch J., Karkoutly C., Mennel H. D., Rossberg C., and Krieglstein J. (1990) Protective effect of nimodipine against ischemic neuronal damage in rat hippocampus without changing postischemic cerebral blood flow. J. Cereb. Blood Flow Metab. 10, 654-659.
221. Olney J. W. (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721.
222. Ozawa H., Keane R. W., Marcillo A. E., Diaz P. H., and Dietrich W. D. (2002) Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats. Exp. Neurol. 177, 306-313.
223. Pak K., Chan S. L., and Mattson M. P. (2003) Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities and exacerbates which matter damage and memory impairment in mice. Neuromolecular Med. (In press.)
224. Pappas I. S. and Parnavelas J. G. (1997) Neurotrophins and basic fibroblast growth factor induce the differentiation of calbindin-containing neurons in the cerebral cortex. Exp. Neurol. 144, 302-314.
225. Parks J. K., Smith T. S., Trimmer P. A., Bennett J. P., and Parker W. D. (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 76, 1050-1056.
226. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S. H., Smith R. G, Kasarskis E., and Mattson M. P. (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in spinal cord tissue of ALS patients. Ann. Neurol. 44, 819-824.
227. Pedersen W. A., McCullers D., Culmsee C., Haughey N. J., Herman J. P., and Mattson M. P. (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8, 492-503.
228. Pedersen W. A., Wan R., Zhang P., and Mattson M. P. (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404-412.
229. Podolsky S., Leopold N. A., and Sax D. S. (1972) Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1, 1356-1358.
230. Prehn J. H. M., Backhaub C., and Krieglstein J. (1993) Transforming growth factor-β prevents glutamate toxicity in rat neocortical cell cultures and protects mouse from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525.
231. Rabchevsky A. G., Fugaccia I., Turner A. F., Blades D. A., Mattson M. P., and Scheff S. W. (2000) Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp. Neurol. 164, 280-291.
232. Refolo L. M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G. S., Sambamurti K., Duff K., and Pappolla M. A. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321-331.
233. Rosenberg P. A. and Aizenman E. (1989) Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neuroscience 103, 162-168.
234. Rosenmund C. and Westbrook G. (1993) Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10, 805-814.
235. Rothstein J. D., VanKammen B. A., Levey B. A., Martin L. J., and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
236. Sagratella S. (1995) NMDA antagonists: antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles. Pharmacol. Res. 32,1-13.
237. Saroff D., Delfs J., Kuznetsov D., and Geula C. (2000) Selective vulnerability of spinal cord motor neurons to non-NMDA toxicity. Neuroreport 11, 1117-1121.
238. Satoh K., Ikeda Y., Shioda S., Tobe T., and Yoshikawa T. (2002) Edarabone scavenges nitric oxide. Redox. Rep. 7, 219-222.
239. Schapira A. H. (1999) Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta. 1410, 159-170.
240. Scheibel A. B. (1979) Dendritic changes in senile and presenile dementias. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 57, 107-124.
241. Sengpiel B., Preis E., Krieglstein J., and Prehn J. H. (1998) NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur. J. Neurosci. 10, 1903-1910.
242. Seshadri S., Beiser A., Selhub J., Jacques P. E, Rosenberg I. H., D'Agostino R. B., Wilson P. W., and Wolf P. A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483.
243. Shoulson I. (1998) DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Ann Neurol. 44, S160-166.
244. Shults C. W., Oakes D., Kieburtz K., et al. (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59, 1541-1550.
245. Siddique T. and Lalani I. (2002) Genetic aspects of amyotrophic lateral sclerosis. Adv. Neurol. 88, 21-32.
246. Sieradzan K. A. and Mann D. M. (2001) The selective vulnerability of nerve cells in Huntington's disease. Neuropathol. Appl. Neurobiol. 27, 1-21.
247. Simpson E. P., Mosier D., and Appel S. H. (2002) Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. Adv. Neurol. 88, 1-19.
248. Sisodia S. S. and St George-Hyslop P. H. (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290.
249. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E., and Mattson M. P. (1994) Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63, 781-784.
250. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15, 5840-5850.
251. Smith-Swintosky V. L., Pettigrew L. C., Sapolsky R. M., Phares C., Craddock S. D., Brooke S. M., and Mattson M. P. (1996) Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J. Cerebr. Blood Flow Metab. 16, 585-598.
252. Sommer B., Burnashev N., Verdoorn T. A., Keinanen K., Sakmann B., and Seeburg P. H. (1992) A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11, 1651-1656.
253. Sonsalla P. K., Albers D. S., and Zeevalk G. D. (1998) Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism. Amino Acids. 14, 69-74.
254. Sperk G., Lassmann H., Baran H., Kish S. J., Seitelberger F., and Hornykiewicz O. (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10, 1301-1315.
255. Springer J. E., Azbill R. D., Mark R. J., Begley J. G., Waeg G., and Mattson M. P. (1997) 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68, 2469-2476.
256. Stein-Behrens B., Mattson M. P., Chang I., Yeh M., and Sapolsky R. M. (1994) Stress excacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373-5380.
257. Stoll G., Jander S., and Schroeter M. (1998) Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56, 149-171.
258. Sullivan P. G., Geiger J. D., Mattson M. P., and Scheff S. W. (2000) Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 48, 723-729.
259. Swann J. W., Al-Noori S., Jiang M., and Lee C. L. (2000) Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10, 617-625.
260. Tahraoui S. L., Marret S., Bodenant C., Leroux P., Dommergues M. A., Evrard P., and Gressens P. (2001) Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol. 11, 56-71.
261. Tanzi R. E. and Bertram L. (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184.
262. Tatlisumak T., Takano K., Meiler M. R., and Fisher M. (1998) A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Stroke 29, 190-195.
263. Turski L., Bressler K., Rettig K. J., Loschmann P. A., and Wachtel H. (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-418.
264. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11, 221-235.
265. Uchino H., Minamikawa-Tachino R., Kristian T., Perkins G., Narazaki M., Siesjo B. K., and Shibasaki F. (2002) Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol. Dis. 10, 219-233.
266. Vergun O., Sobolevsky A. I., Yelshansky M. V., Keelan J., Khodorov B. I., and Duchen M. R. (2001) Exploration of the role of reactive oxygen species in glutamate neurotoxicityin rat hippocampal neurones in culture. J. Physiol. 531, 147-163.
267. Volbracht C., Fava E., Leist M., and Nicotera P. (2001) Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis. Neuroreport 12, 3645-3648.
268. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
269. Wada K., Alonso O. F., Busto R., Panetta J., Clemens J. A., Ginsberg M. D., and Dietrich W. D. (1999) Early treatment with a novel inhibitor of lipid peroxidation (LY341122) improves histopathological outcome after moderate fluid percussion brain injury in rats. Neurosurgery 45, 601-608.
270. 2+ loads. J. Neurophysiol. 72, 2563-2569.
271. Wang Y., Mattson M. P., and Furukawa K. (2002) Endoplasmic reticulum calcium release is modulated by actin polymerization. J. Neurochem. 82, 945-952.
272. Wei H. and Perry D. C. (1996) Dantrolene is cytoprotective in two models of neuronal cell death. J. Neurochem. 67, 2390-2398.
273. Weiss J. H., Hartley D. M., Koh J., and Choi D. W. (1990) The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 247, 1474-1477.
274. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
275. Werth J. L. and Thayer S. A. (1994) Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J. Neurosci. 14, 348-356.
276. Wolz P. and Krieglstein J. (1996) Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology 35, 369-375.
277. Yakovlev A. G., Knoblach S. M., Fan L., Fox G. B., Goodnight R., and Faden A. I. (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17, 7415-7424.
278. Yoshioka A., Bacskai B., and Pleasure D. (1996) Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 46, 427-437.
279. Yu Z. E, Bruce-Keller A. J., Goodman Y., and Mattson M. P. (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 53, 613-625.
280. Yu Z. F. and Mattson M. P. (1999) Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57, 830-839.
281. Yu Z., Luo H., Fu W., and Mattson M. P. (1999) The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 155, 302-314.
282. Zuccato C., Ciammola A., Rigamonti D., et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498.